Holen Sie sich die Stockscreener-App
140.00
0.19%
0.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EFX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$139.73
Offen:
$138.37
24-Stunden-Volumen:
3.46M
Relative Volume:
2.26
Marktkapitalisierung:
$16.45B
Einnahmen:
$6.28B
Nettoeinkommen (Verlust:
$703.80M
KGV:
24.65
EPS:
5.6784
Netto-Cashflow:
$1.14B
1W Leistung:
-5.48%
1M Leistung:
-24.52%
6M Leistung:
-23.24%
1J Leistung:
-39.75%
1-Tages-Spanne:
$137.91
$144.64
1-Wochen-Bereich:
$137.01
$147.41
52-Wochen-Spanne:
$137.01
$244.37
Equifax Inc Stock (EFX) Company Profile
Firmenname
Equifax Inc
Sektor
Branche
Telefon
(404) 885-8000
Adresse
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
140.00 | 17.40B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
163.88 | 22.02B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
67.35 | 8.77B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
136.40 | 3.71B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
162.15 | 2.51B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Fortgesetzt | BofA Securities | Buy |
| 2025-10-13 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-01 | Eingeleitet | Seaport Research Partners | Neutral |
| 2025-07-10 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-06-23 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-04-10 | Fortgesetzt | BofA Securities | Buy |
| 2025-04-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2025-02-11 | Herabstufung | Argus | Buy → Hold |
| 2024-12-16 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-12-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-01 | Eingeleitet | UBS | Buy |
| 2024-09-19 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-08-13 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-09 | Eingeleitet | Wolfe Research | Outperform |
| 2024-02-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-01-11 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2024-01-08 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-01-04 | Bestätigt | Needham | Buy |
| 2023-12-19 | Eingeleitet | Oppenheimer | Outperform |
| 2023-12-18 | Hochstufung | Jefferies | Hold → Buy |
| 2023-12-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-11-20 | Eingeleitet | Citigroup | Buy |
| 2023-07-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-11-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2022-10-21 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-10-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-13 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-04-21 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-03-30 | Eingeleitet | Deutsche Bank | Hold |
| 2022-03-11 | Fortgesetzt | BofA Securities | Neutral |
| 2022-01-31 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-01-27 | Hochstufung | Truist | Hold → Buy |
| 2022-01-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-01-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-22 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-10-22 | Hochstufung | Argus | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2021-07-23 | Bestätigt | Goldman | Neutral |
| 2021-07-08 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2020-12-15 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-12-11 | Hochstufung | Stifel | Hold → Buy |
| 2020-12-08 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-10-07 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-10-06 | Eingeleitet | Needham | Buy |
| 2020-07-10 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-06-09 | Herabstufung | SunTrust | Buy → Hold |
| 2020-05-15 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-04-06 | Herabstufung | Argus | Buy → Hold |
| 2020-03-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-02 | Hochstufung | Exane BNP Paribas | Underperform → Outperform |
| 2020-01-17 | Hochstufung | Argus | Hold → Buy |
| 2019-11-22 | Eingeleitet | Jefferies | Buy |
| 2019-03-15 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2019-02-05 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2018-12-07 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-10-26 | Bestätigt | Barclays | Equal Weight |
| 2018-10-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-04-10 | Eingeleitet | BofA/Merrill | Underperform |
| 2017-12-14 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Equifax Inc Aktie (EFX) Neueste Nachrichten
Equifax stock after-hours at EUR 125.90: plus 3.71 percent versus Lang & Schwarz prior close - AD HOC NEWS
BMO cuts Equifax stock target from USD 179.00 to USD 160.00 - AD HOC NEWS
Equifax customers can now file claims for part of $100 million settlement over credit scores - ctinsider.com
EFX Maintained by BMO Capital -- Price Target Lowered to $160 - GuruFocus
Autonomous Research Adjusts Price Target on Equifax to $186 From $194, Maintains Neutral Rating - Moomoo
These 10 industrials stocks suffered the steepest September declines - TradingView
What to Expect From Equifax's Q3 2026 Earnings Report - Barchart.com
BMO Capital Adjusts Price Target on Equifax to $160 From $179, Maintains Market Perform Rating - marketscreener.com
ETFs Investing in Equifax Inc. Stocks - TradingView
Why Equifax (EFX) Shares Are Sliding Today - Yahoo Finance
Is Equifax Inc (EFX) a Bargain After 3.4% Drop? GF Value Says Un - GuruFocus
Equifax Inc. Revenue Breakdown – HAN:EFX - TradingView
Here's how to file a claim for the $100 million Equifax credit reporting error class action settlement! - Claim Depot
Equifax: The Signs Are There, But An Imminent Re-Rating May Not Be Forthcoming (EFX) - Seeking Alpha
Equifax Canada Reports Rising Credit Card Application Fraud Amid Continued Consumer Financial Pressure - Quiver Quantitative
Goldman Sachs Adjusts Price Target on Equifax to $171 From $199, Maintains Neutral Rating - marketscreener.com
Credit Card Application Fraud Climbs as Identity Thieves Disproportionately Target Canadians Aged 56 to 65 - Yahoo Finance
Equifax Inc. stock outperforms competitors despite losses on the day - MarketWatch
Equifax Second Quarter 2026 Market Pulse Index Report Sees First Pause in K-Shaped Economic Widening in Three Years - PR Newswire
Equifax (EFX) Stock Still Looks Undervalued Despite Its 41% Slide - Yahoo Finance
Equifax Inc Lobbying Profile, 1998 - OpenSecrets
Equifax (EFX) Hits a 52-Week Low. The Shares Are Down 42% From Their High - Yahoo Finance
Can OneTru Help TransUnion Sustain Its Growth Momentum? - TradingView
Debt Management Services Market Poised for Growth Through 2035, Driven by Cloud Adoption, Expanding End-User Demand and Regional Opportunities - GlobeNewswire Inc.
Equifax stock falls 4.20 percent ahead of the open - AD HOC NEWS
A Look at Equifax Inc (EFX) After 4.2% Decline -- GF Value $293. - GuruFocus
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Why Equifax (EFX) Stock Is Down Today - Quiver Quantitative
Equifax stock hits 52-week low at 150.63 USD By Investing.com - za.investing.com
The Tri-Merge Credit Report: More Data Drives Better Decisions - marketscreener.com
Equifax stock slips 2.95 percent ahead of the open - AD HOC NEWS
Equifax Inc. (EFX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Equifax Inc. (EFX) Options ChainYahoo Finance - Yahoo! Finance Canada
Equifax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Equifax overhauls broker credit report, moves to soft inquiry - Canadian Mortgage Trends
Equifax Inc. Launches Signal Score for Email and Signal Score for Device - marketscreener.com
Equifax Launches Real-Time Fraud Detection Tools - Intellectia AI
Equifax launches two new intelligence solutions to help businesses mitigate automated fraud - PR Newswire
Equifax stock holds near USD 160 after an EPS beat - AD HOC NEWS
Equifax stock heads into the open after closing at USD 160.11 - AD HOC NEWS
Equifax stock holds near USD 159 after earnings beat - AD HOC NEWS
Equifax stock holds near USD 159 as earnings beat estimates - AD HOC NEWS
Equifax launches automated healthcare credentia... - Pluang
Equifax introduces Healthcare Report™ Credential ID - PR Newswire
Equifax Inc. stock gains as Q2 revenue rises 10.6 percent - AD HOC NEWS
Equifax Price Target Cut to $200.00/Share From $212.00 by Wells Fargo - moomoo.com
Nationwide taps Equifax to give customers free access to their credit scores - Finextra Research
Wells Fargo Adjusts Price Target on Equifax to $200 From $212, Keeps Overweight Rating - marketscreener.com
Equifax Inc. stock edges lower as housing warning puts earnings outlook in focus - AD HOC NEWS
Equifax Stock Price Forecast. Should You Buy EFX? - StockInvest.us
Equifax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Finanzdaten der Equifax Inc-Aktie (EFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):